Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 51 device-driven procedures, CMS 2024
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 50 | 5,185−16%/yr | −16%/yr | 5.10.9× | 61% | 5,340 in 2030+0.5%/yr |
| Superficial venous ablation |
How the numbers are made · Every state · Compare two markets
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 57 |
| 3,844−3.8%/yr |
| −3.8%/yr |
| 3.50.6× |
| 94% |
| 4,330 in 2030+2%/yr |
| Peripheral arterial intervention | 30 | 3,751−7.6%/yr | −7.6%/yr | 3.50.5× | 43% | 5,530 in 2030+6.7%/yr |
| Carotid revascularization | 28 | 1,070−3.9%/yr | −3.9%/yr | 1.00.8× | 0% | 1,290 in 2030+3.1%/yr |
| Thrombectomy, IVC filters & venous stents | 4 | 1,041−5.6%/yr | −5.6%/yr | 1.00.6× | 2% | 1,720 in 2030+8.7%/yr |
| Aortic endografts (EVAR/TEVAR) | 3 | 443−6.2%/yr | −6.2%/yr | 0.40.9× | 0% | 440 in 2030−0.2%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.